The University of Southampton
University of Southampton Institutional Repository

Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study

Ahmed, A., Turner, G., King, B., Jones, L., McCance, D., Ardill, J., Johnston, B.T., Poston, G., Rees, M., Buxton - Thomas, M., Caplin, M. and Ramage, J.K. (2009) Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study Endocrine-Related Cancer, 16, (3), pp. 885-894. (doi:10.1677/ERC-09-0042). (PMID:19458024).

Record type: Article


We intended to identify the prognostic factors and the results of interventions on patients with liver metastatic midgut carcinoids. Five institutions that are part of United Kingdom and Ireland neuroendocrine tumour (NET) group took part in this study. Patients were included if they had histology proven NET of midgut origin and liver metastases at the time of the study. Clinical and biochemical data were collected retrospectively from hospital charts, pathology reports, radiology reports and biochemistry records for each patient. Three hundred and sixty patients were included in the study. The median survival from date of diagnosis was 7.69 years (confidence interval (CI) 6.40–8.99) and 5.95 years (CI 5.02–6.88) from date of diagnosis of liver metastases. On univariate analysis, increasing age at diagnosis, increasing urinary hydroxyindole acetic acid levels, increasing plasma chromogranin A levels, high Ki67, high tumour volume and treatment with chemotherapy were identified as factors associated with a significantly poorer outcome. Resection of liver metastases, resection of small bowel primary, treatment with somatostatin analogue therapy and treatment with peptide receptor therapy were associated with improved prognosis. Multivariate analysis revealed that age at diagnosis (P=0.014), Ki67 level (P=0.039) and resection of primary (P=0.015) were independent predictors of survival. This is the largest study to our knowledge looking specifically at the prognosis and clinical course of patients with liver metastatic midgut NETs. For the first time, we have shown that Ki67 and resection of primary are independent predictors of survival for this group of patients.

Full text not available from this repository.

More information

Published date: September 2009


Local EPrints ID: 143783
ISSN: 1351-0088
PURE UUID: 57c43b53-1544-461c-8599-2ed98f3c5c51

Catalogue record

Date deposited: 13 Apr 2010 09:05
Last modified: 18 Jul 2017 23:09

Export record



Author: A. Ahmed
Author: G. Turner
Author: B. King
Author: L. Jones
Author: D. McCance
Author: J. Ardill
Author: B.T. Johnston
Author: G. Poston
Author: M. Rees
Author: M. Buxton - Thomas
Author: M. Caplin
Author: J.K. Ramage

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton:

ePrints Soton supports OAI 2.0 with a base URL of

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.